You are here:

Archived: Bemiparin, 3500 IU in 0.2 ml injection for sub-cutaneous administration (Zibor®)

Advice

Following a full submission

Bemiparin (Zibor) is not recommended for use within NHS Scotland for the prevention of thromboembolic events in patients undergoing orthopaedic surgery.

Bemiparin was associated with a lower incidence of thromboembolic complications than unfractionated heparin and was non-inferior to another low molecular weight heparin.

The cost effectiveness has not been convincingly addressed for the Scottish context.

Drug Details

Drug Name: Bemiparin, 3500 IU in 0.2 ml injection for sub-cutaneous administration (Zibor®)
SMC Drug ID: 204/05
Manufacturer: Amdipharm PLC
Indication: Prevention of thromboembolic disease in patients undergoing orthopaedic surgery
BNF Category:
Sub Category: 2.8 Anticoagulants and protamine
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 10 October 2005

Current Advice

Resubmission 7 December 2009

Archived Advice

Resubmission 9 July 2007

Back